GCG and Insulin resistance: Despite the low bioavailability of PHZ and absorption to the bloodstream to act via competitive inhibition of the SGLTs, our findings supported that the combined action of some effector molecules, e.g., SCFAs and GLP-2, together contributed to the amelioration of HFD-induced MDs, as indicated by an improved insulin resistance (Figure 5).